Oragenics Files 8-K on Feb 27, 2024
Ticker: OGEN · Form: 8-K · Filed: Feb 28, 2024 · CIK: 1174940
Sentiment: neutral
Topics: regulatory-filing, corporate-update
TL;DR
**Oragenics filed a routine 8-K on Feb 27, 2024, signaling a disclosure event.**
AI Summary
Oragenics, Inc. filed an 8-K on February 27, 2024, under Regulation FD Disclosure and Financial Statements and Exhibits. The filing indicates a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. The company, incorporated in Florida with IRS Employer Identification Number 59-3410522, maintains its principal executive offices at 1990 Main Street, Suite 750, Sarasota, FL 34236.
Why It Matters
This filing provides basic corporate information and indicates a disclosure event, which could precede more significant news for investors.
Risk Assessment
Risk Level: low — This 8-K is a standard disclosure filing and does not contain information indicating immediate financial risk.
Key Players & Entities
- Oragenics, Inc. (company) — Registrant
- February 27, 2024 (date) — Date of earliest event reported
- Florida (location) — State of incorporation
- 59-3410522 (other) — IRS Employer Identification Number
- 1990 Main Street, Suite 750, Sarasota, FL 34236 (location) — Principal executive offices
FAQ
What is the filing date of this 8-K for Oragenics, Inc.?
The filing date for this 8-K is February 28, 2024, with the earliest event reported on February 27, 2024.
What is the business address of Oragenics, Inc. as stated in the filing?
The business address of Oragenics, Inc. is 1990 Main Street, Suite 750, Sarasota, FL 34236.
Under which items was this 8-K filed?
This 8-K was filed under Regulation FD Disclosure and Financial Statements and Exhibits.
What is the state of incorporation for Oragenics, Inc.?
Oragenics, Inc. is incorporated in Florida.
What is the Commission File Number for Oragenics, Inc.?
The Commission File Number for Oragenics, Inc. is 001-32188.
Filing Stats: 832 words · 3 min read · ~3 pages · Grade level 12.8 · Accepted 2024-02-27 17:48:39
Filing Documents
- form8-k.htm (8-K) — 41KB
- ex99-1.htm (EX-99.1) — 12KB
- 0001493152-24-008022.txt ( ) — 227KB
- ogen-20240227.xsd (EX-101.SCH) — 3KB
- ogen-20240227_lab.xml (EX-101.LAB) — 33KB
- ogen-20240227_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on this 27 th day of February, 2024. ORAGENICS, INC. (Registrant) BY: /s/ Janet Huffman Janet Huffman Chief Financial Officer